このエピソードについて

英語
アメリカ合衆国

文字起こし 🔗

過去のエピソードを検索

Addiction Medicine Journal Clubの以前のエピソードを検索します。

このポッドキャストの他のエピソード

AMJC Poster Session

We love a good poster session. This episode we are joined by Dr. Anthony Accurso to review some of our favorite posters from the American Society of Addiction Medicine’s 2026 Annual Meeting.  All the Posters from ASAM 57    Posters profiled here:  12: Real-World Analysis of Buprenorphine-…
Finally, an external validation of Epic’s controversial risk of opioid abuse and overdose model.    Hooker, S.A., Rossom, R.C., Haapala, J. et al. External Validation of Epic’s Risk of Opioid Abuse and Overdose Model Among Primary Care Patients in Three Health Systems. J GEN INTERN MED (2026).   …
In episode 75 we discuss the mortality benefit of contingency management for stimulant use disorder.    Coughlin LN, Tomlinson DC, Zhang L, Kim HM, Frost MC, Khazanov G, McKay JR, DePhilippis D, Lin LA. Contingency Management for Stimulant Use Disorder and Association With Mortality: A Cohort Stu…
A new randomized controlled trial of injectable buprenorphine in pregnancy.    Winhusen TJ, Lofwall MR, Kropp F, et al. Extended-Release vs Sublingual Buprenorphine in Pregnancy Through 12 Months Post Partum: A Randomized Clinical Trial. JAMA Intern Med. Published online March 16, 2026.     We …
In episode 74 we discuss an article about starting injectable buprenorphine after just one sublingual dose.    Shiwach R, Le Foll B, Alho H, et al. Rapid vs Standard Induction to Injectable Extended-Release Buprenorphine: A Randomized Clinical Trial. JAMA Netw Open. 2025;8(10):e2537319.     We …
免責: このページに埋め込まれているポッドキャストとアートワークは Sonya Del Tredici and John Keenan からのものであり、その所有者の所有物であり、Listen Notes, Inc. と提携または承認されていません。